What are the side effects of mifepristone?

Mifepristone tablets are a drug used by early pregnant women to induce abortion. After taking them, early pregnant women may experience mild nausea, vomiting, dizziness, fatigue, lower abdominal pain, anal swelling, uterine bleeding, and other symptoms. Some women may also have rashes. These symptoms are all side effects of the drug. Mifepristone tablets are prohibited from being used at other times except to terminate early pregnancy. Women are advised to be cautious when using them.

Mifepristone tablets are suitable for early pregnant women within 49 days after menopause to achieve the purpose of termination of pregnancy. This product is contraindicated for patients with heart, liver, kidney and adrenal insufficiency. It is not recommended for intrauterine pregnancy or patients with suspected ectopic pregnancy. When it comes to abortion, women must consider the side effects of the drugs when choosing them. So, what are the side effects of mifepristone?
Mifepristone is a drug used clinically for abortion. Mifepristone tablets have the effects of terminating early pregnancy, preventing implantation, inducing menstruation and promoting cervical ripening. It is used in combination with prostaglandin drugs to terminate pregnancy for women who are pregnant within 49 days after menopause. Side effects refer to pharmacological effects other than the therapeutic purpose that occur after the administration of therapeutic doses of drugs.
This drug usually has many effects, both for therapeutic purposes and for non-therapeutic purposes. Under certain conditions, side effects and therapeutic effects can be transformed. Side effects are usually short-lived and disappear as the therapeutic effect disappears, and sometimes they can also cause sequelae.
Mifepristone side effects may include nausea, vomiting, dizziness, abdominal pain and fatigue, transient liver dysfunction in some women, and occasionally rash. Prostaglandins may cause fever, itchy palms, abdominal pain and anal swelling.
In addition, some gastrointestinal symptoms are more obvious, and contractions of the lower part of the uterus are also obvious, which are some of the side effects of mifepristone. Some women bleed too much for a long time, which can lead to anemia, endometritis and pelvic inflammatory disease. Rarely, there is heavy bleeding.
During treatment or follow-up, patients taking mifepristone tablets should seek medical help if heavy bleeding or other abnormal conditions occur. 8-15 days after taking the medicine, they should go to the original treatment unit for follow-up to determine the effect of abortion. If necessary, B-ultrasound or blood HCG measurement should be performed. If it is diagnosed that the pregnancy is continuing, other treatment methods should be selected in time to avoid causing greater harm to the pregnant woman.